News

New EU financing instrument of up to €150 million to support European artificial intelligence companies

Published on: 09/12/2020

New EU financing instrument of up to €150 million to support European artificial intelligence companies
European Commission, Funding
Member News, Funding news

Yesterday at the Web Summit in Lisbon, the European Investment Bank (EIB) together with the European Investment Fund (EIF) launched a new financing instrument, in the form of a co-investment facility of up to €150 million, to support artificial intelligence companies across Europe.

graphic showing a hand and a digitised version of a brain

The initiative, which is part of the EU’s overall support to the European ecosystem of excellence and trust in AI and the Commission’s European Digital Strategy, will mainly target companies in their early or growth-stage, investing in the development of breakthrough AI applications and technologies that directly complement AI, such as Blockchain, the Internet of Things and robotics. It complements and builds on EIB and EIF expertise in the sector, developed through the existing €100 million Artificial Intelligence/Blockchain pilot under InnovFin Equity and direct EIB financing for AI companies through its venture debt instrument

Thierry Breton, Commissioner for Internal Market, said: 

Europe has all it takes to become a hub for cutting-edge developments in Artificial Intelligence. We have the talent and a wealth of industrial data – both of which will give us an important comparative advantage in AI if we use them wisely. We are putting a framework in place to leverage our strengths and build trust – including through clear and predictable rules. The co-investment facility announced today will further support companies so that they can grow in the EU thanks to the design and the deployment of trustworthy AI. 

By collaborating with private investors, the European Investment Bank expects to support approximately 20-30 small and medium-sized companies. The new funds will be available in the EU and in Horizon 2020 associated countries and are expected to be deployed during the next four years.

NEWS​

Related News

VUGENE secures 1 million Euros to revolutionize biological research

7 May 2025
VUGENE, a Lithuania-based multi-omics data analysis company, has announced the closing an investment round of €1 million, led by Superhero Capital tog...

AMR EDUCare: Empowering europe’s healthcare professionals to tackle antimicrobial resistance

6 May 2025

Connect, Innovate, and Transform Healthcare at the AHB Symposium 2025

6 May 2025

Shaping the Future of Digital Health: Insights from the Foresight 2030 Study

6 May 2025

MedFIT 2025

6 May 2025

Have your say: Open Public Consultation for the BeWell Skills Strategy (DUPLICATE)

6 May 2025

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *